{
  "id": [
    "25277199"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "25277199"
  ],
  "pmcid": [
    "PMC4202155"
  ],
  "title": [
    "Expression and functions of galectin-7 in ovarian cancer."
  ],
  "authorString": [
    "Labrie M, Vladoiu MC, Grosset AA, Gaboury L, St-Pierre Y."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Labrie M"
          ],
          "firstName": [
            "Marilyne"
          ],
          "lastName": [
            "Labrie"
          ],
          "initials": [
            "M"
          ],
          "affiliation": [
            "INRS-Institut Armand-Frappier, Laval, Québec, Canada."
          ]
        },
        {
          "fullName": [
            "Vladoiu MC"
          ],
          "firstName": [
            "Maria Claudia"
          ],
          "lastName": [
            "Vladoiu"
          ],
          "initials": [
            "MC"
          ],
          "affiliation": [
            "INRS-Institut Armand-Frappier, Laval, Québec, Canada."
          ]
        },
        {
          "fullName": [
            "Grosset AA"
          ],
          "firstName": [
            "Andrée-Anne"
          ],
          "lastName": [
            "Grosset"
          ],
          "initials": [
            "AA"
          ],
          "affiliation": [
            "INRS-Institut Armand-Frappier, Laval, Québec, Canada."
          ]
        },
        {
          "fullName": [
            "Gaboury L"
          ],
          "firstName": [
            "Louis"
          ],
          "lastName": [
            "Gaboury"
          ],
          "initials": [
            "L"
          ],
          "affiliation": [
            "Institute for Research in Immunology and Cancer, P.O. Box 6128, Downtown Station, Montréal, Québec, Canada."
          ]
        },
        {
          "fullName": [
            "St-Pierre Y"
          ],
          "firstName": [
            "Yves"
          ],
          "lastName": [
            "St-Pierre"
          ],
          "initials": [
            "Y"
          ],
          "affiliation": [
            "INRS-Institut Armand-Frappier, Laval, Québec, Canada."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "17"
      ],
      "volume": [
        "5"
      ],
      "journalIssueId": [
        "2205514"
      ],
      "dateOfPublication": [
        "2014 Sep"
      ],
      "monthOfPublication": [
        "9"
      ],
      "yearOfPublication": [
        "2014"
      ],
      "printPublicationDate": [
        "2014-09-01"
      ],
      "journal": [
        {
          "title": [
            "Oncotarget"
          ],
          "ISOAbbreviation": [
            "Oncotarget"
          ],
          "medlineAbbreviation": [
            "Oncotarget"
          ],
          "NLMid": [
            "101532965"
          ],
          "ESSN": [
            "1949-2553"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2014"
  ],
  "pageInfo": [
    "7705-7721"
  ],
  "abstractText": [
    "There is a critical need to develop effective new strategies for diagnosis and treatment of ovarian cancer. In the present work, we investigated the expression of galectin-7 (gal-7) in epithelial ovarian cancer (EOC) cells and studied its functional relevance. Immunohistochemical analysis of gal-7 expression in tissue microarrays showed that while gal-7 was not detected in normal ovarian tissues, positive cytoplasmic staining of gal-7 was detected in epithelial cells in all EOC histological subtypes but was more frequent in high grade tumors and metastatic samples. Gal-7 expression correlated with a significant difference in the overall survival of patients with ovarian serous cystadenocarcinoma. Furthermore, using human EOC cell lines, we found that gal-7 expression was induced by mutant p53. Mechanistically, Matrigel invasion assays and live cell imaging showed that gal-7 increased the invasive behavior of ovarian cancer cells by inducing MMP-9 and increasing cell motility. EOC cells can also secrete gal-7. Recombinant human gal-7 kills Jurkat T cells and human peripheral T cells, suggesting that gal-7 also has immunosuppressive properties. Taken together, our study validates the clinical significance of gal-7 overexpression in ovarian cancer and provides a rationale for targeting gal-7 to improve the outcome of patients with this disease."
  ],
  "affiliation": [
    "INRS-Institut Armand-Frappier, Laval, Québec, Canada."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Line, Tumor"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neoplasms, Glandular and Epithelial"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cystadenocarcinoma, Serous"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Ovarian Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Galectins"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Fluorescent Antibody Technique"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Blotting, Western"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Tissue Array Analysis"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunohistochemistry"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Transfection"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Reverse Transcriptase Polymerase Chain Reaction"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "LGALS7 protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Galectins"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4202155?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4202155"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "6"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "Y"
  ],
  "dbCrossReferenceList": [
    {
      "dbName": [
        "UNIPROT"
      ]
    }
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2015-08-06"
  ],
  "dateOfCreation": [
    "2014-10-03"
  ],
  "firstPublicationDate": [
    "2014-09-01"
  ]
}